Kernal gets $48M to develop easier, cheaper CAR T-cell therapies
Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell therapy.| Multiple Sclerosis News Today
October 20, 2025 – The 2025 Nobel Prize in Medicine was awarded to Professor Shimon Sakaguchi, Professor Mary E. Brunkow, and Dr. Fred Ramsdell for their groundbreaking discoveries about regulatory T cells and the concept of immune tolerance. Their work has reshaped our understanding of The post Rambam Expert Weighs in on Nobel Prize in Medicine appeared first on American Friends of Rambam Medical Center.| American Friends of Rambam Medical Center
Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell therapy.| Multiple Sclerosis News Today
Telomere damage drives T cell exhaustion. Antioxidants restored their cancer-fighting strength in mice. Tumor environments place heavy stress on immune cells that fight cancer. Limited oxygen, elevated acidity, and other harsh conditions overload mitochondria, the cell’s energy producers, which c| SciTechDaily
Iaso Bio has received clearance from the FDA to start clinical trials to test its CAR T-cell therapy equecabtagene autoleucel in MS patients.| Multiple Sclerosis News Today
